|
|
Volumn 93, Issue 5, 2011, Pages 571-577
|
|
Implications of TNF-α in the pathogenesis and management of GVHD.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
MONOCLONAL ANTIBODY;
TUMOR NECROSIS FACTOR ALPHA;
TUMOR NECROSIS FACTOR RECEPTOR 1;
APOPTOSIS;
BONE MARROW TRANSPLANTATION;
CELL MOTION;
CELL PROLIFERATION;
CLINICAL TRIAL (TOPIC);
DRUG EFFECT;
FEMALE;
GRAFT VERSUS HOST REACTION;
HEMATOLOGIC DISEASE;
HUMAN;
IMMUNOLOGY;
MALE;
METABOLISM;
MORTALITY;
PATHOLOGY;
PATHOPHYSIOLOGY;
REVIEW;
RISK FACTOR;
SECRETION;
SURVIVAL;
T LYMPHOCYTE;
ANTIBODIES, MONOCLONAL;
APOPTOSIS;
BONE MARROW TRANSPLANTATION;
CELL MOVEMENT;
CELL PROLIFERATION;
CLINICAL TRIALS AS TOPIC;
FEMALE;
GRAFT VS HOST DISEASE;
HEMATOLOGIC DISEASES;
HUMANS;
MALE;
RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I;
RISK FACTORS;
SURVIVAL ANALYSIS;
T-LYMPHOCYTES;
TUMOR NECROSIS FACTOR-ALPHA;
|
|
EID: 80052893511
PISSN: None
EISSN: 18653774
Source Type: Journal
DOI: 10.1007/s12185-011-0803-1 Document Type: Review |
|
Times cited : (66)
|
|
References (0)
|
